EPHA2 and renal cell carcinoma: Collectively, our results contribute to a broader comprehension of the mechanisms driving RCC tumorigenesis, highlighting potential molecular pathways involving RSK4, RUNX1, and EPHA2 in the specific context of RCC cell lines.